Immunohistochemistry
This policy defines reimbursement and coding guidance for immunohistochemistry (IHC) laboratory procedures for BCBSNM products and governs provider claim submission and coding expectations; applicability may vary by specific plan document.
No material clinical or coverage changes in this revision.
Immunohistochemistry (IHC) Coverage and Reimbursement
IHC coverage and reimbursement criteria
Reimbursement guidance and applicability
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.